相关实验视频

Updated: Jul 6, 2025

Electrophysiological Assessment of Murine Atria with High-Resolution Optical Mapping

Electrophysiological Assessment of Murine Atria with High-Resolution Optical Mapping

Published on: February 22, 2018

染色体4q25 (rs17570669) 上的遗传多态可能预测持续性心房的患者在成功的电动心脏转换后的复发

Taner Ulus¹, İlkin Aliyev¹, Serap Arslan²

¹Department of Cardiology, Eskişehir Osmangazi University, Eskişehir, Türkiye.

Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir

|January 2, 2024

概括

对心房动 (AF) 的直流电动心脏转变 (DCCV) 的复发率很高. 一种特定的PITX2基因单核酸多态 (SNP),rs17570669,被确定为土耳其人群中DCCV后AF复发的独立预测因子.

科学领域:

心脏病学心脏病学
遗传学是一个遗传学.
医学科学医学科学医学科学

背景情况:

直流电动心脏转换 (DCCV) 是对心房动 (AF) 的主要节律控制策略.
在DCCV后的高AF复发率构成了重大的临床挑战.
有限的研究存在于影响DCCV后AF复发的遗传因素.

研究的目的:

调查11个先前识别的AF相关单核酸多态 (SNP) 是否在成功的DCCV后预测复发.
为了评估土耳其人口中的这些遗传预测因素.

主要方法:

在DCCV后,75名患有持续性AF的患者获得了稳定的鼻节律,被前性监测.
分析了临床数据和11个AF相关的SNP.
进行了AF复发和没有复发的患者之间的统计比较.

主要成果:

在平均17个月的随访期间,在50.7%的患者中观察到AF复发.
在PITX2 (rs17570669) 和ZFHX3 (rs2106261) 基因中的SNP与AF复发有关.
多变量分析确定了PITX2 rs17570669 SNP作为AF复发的唯一独立预测因子 (HR:3.59,P=0.040).

结论:

在PITX2基因中的单核酸多态 rs17570669 是AF复发的独立预测因子.
这一发现凸显了遗传因素在AF复发后电心脏转变中的潜在作用.

更多相关视频

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes

Published on: March 12, 2013

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

相关概念视频

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...

Disturbances in Heart Rhythm

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...

Electrocardiogram

Electrocardiogram

An electrocardiogram (ECG or EKG) is a critical diagnostic tool that records the electrical signals produced by the heart during each heartbeat. This recording is achieved through electrodes placed strategically on the arms, legs, and chest. The electrocardiograph amplifies these signals and produces 12 distinct tracings, offering a comprehensive understanding of the heart's electrical activity.
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...